Literature DB >> 30287093

Nuclear Factor One X in Development and Disease.

Michael Piper1, Richard Gronostajski2, Graziella Messina3.   

Abstract

The past decade has seen incredible advances in the field of stem cell biology that have greatly improved our understanding of development and provided important insights into pathological processes. Transcription factors (TFs) play a central role in mediating stem cell proliferation, quiescence, and differentiation. One TF that contributes to these processes is Nuclear Factor One X (NFIX). Recently, NFIX activity has been shown to be essential in multiple organ systems and to have important translational impacts for human health. Here, we describe recent studies showing the contribution of NFIX to muscle development and muscular dystrophies, hematopoiesis, cancer, and neural stem cell biology, highlighting the importance of this knowledge in the development of therapeutic targets.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NFIX; development; disease; muscular dystrophy

Mesh:

Substances:

Year:  2018        PMID: 30287093     DOI: 10.1016/j.tcb.2018.09.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  14 in total

1.  Improving representations of genomic sequence motifs in convolutional networks with exponential activations.

Authors:  Peter K Koo; Matt Ploenzke
Journal:  Nat Mach Intell       Date:  2021-02-08

2.  Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells.

Authors:  Kunhua Qin; Peng Huang; Ruopeng Feng; Cheryl A Keller; Scott A Peslak; Eugene Khandros; Megan S Saari; Xianjiang Lan; Thiyagaraj Mayuranathan; Phillip A Doerfler; Osheiza Abdulmalik; Belinda Giardine; Stella T Chou; Junwei Shi; Ross C Hardison; Mitchell J Weiss; Gerd A Blobel
Journal:  Nat Genet       Date:  2022-05-26       Impact factor: 41.307

3.  Common Regulatory Targets of NFIA, NFIX and NFIB during Postnatal Cerebellar Development.

Authors:  James Fraser; Alexandra Essebier; Alexander S Brown; Raul Ayala Davila; Danyon Harkins; Oressia Zalucki; Lauren P Shapiro; Peter Penzes; Brandon J Wainwright; Matthew P Scott; Richard M Gronostajski; Mikael Bodén; Michael Piper; Tracey J Harvey
Journal:  Cerebellum       Date:  2020-02       Impact factor: 3.847

4.  Deletion of NFIX results in defective progression through meiosis within the mouse testis†.

Authors:  Raul Ayala Davila; Cassy Spiller; Danyon Harkins; Tracey Harvey; Philip W Jordan; Richard M Gronostajski; Michael Piper; Josephine Bowles
Journal:  Biol Reprod       Date:  2022-06-13       Impact factor: 4.161

5.  Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin.

Authors:  Zhuohao Liu; Ruixiang Ge; Jiayi Zhou; Xinzhi Yang; Kenneth King-Yip Cheng; Jingli Tao; Dinglan Wu; Jie Mao
Journal:  Oncogenesis       Date:  2020-04-14       Impact factor: 7.485

6.  The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation.

Authors:  Debora Libetti; Andrea Bernardini; Sarah Sertic; Graziella Messina; Diletta Dolfini; Roberto Mantovani
Journal:  Cells       Date:  2020-03-24       Impact factor: 6.600

7.  NORFA, long intergenic noncoding RNA, maintains sow fertility by inhibiting granulosa cell death.

Authors:  Xing Du; Lu Liu; Qiqi Li; Lifan Zhang; Zengxiang Pan; Qifa Li
Journal:  Commun Biol       Date:  2020-03-18

8.  CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis.

Authors:  Chenyu Ding; Zanyi Wu; Honghai You; Hongliang Ge; Shufa Zheng; Yuanxiang Lin; Xiyue Wu; Zhangya Lin; Dezhi Kang
Journal:  J Exp Clin Cancer Res       Date:  2019-12-30

9.  Alterations in gene expression in the spinal cord of mice lacking Nfix.

Authors:  Elise Matuzelski; Alexandra Essebier; Lachlan Harris; Richard M Gronostajski; Tracey J Harvey; Michael Piper
Journal:  BMC Res Notes       Date:  2020-09-16

10.  Retinal Genomic Fabric Remodeling after Optic Nerve Injury.

Authors:  Pedro Henrique Victorino; Camila Marra; Dumitru Andrei Iacobas; Sanda Iacobas; David C Spray; Rafael Linden; Daniel Adesse; Hilda Petrs-Silva
Journal:  Genes (Basel)       Date:  2021-03-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.